Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Collagen-Polyvinylpyrrolidone for the Treatment of Hyperinflammation and the Pulmonary Fibrosis in COVID-19 Patients. Double Blind Placebo-controlled Pilot Trial

NCT04517162 is registered in ClinicalTrials.gov with Janette Furuzawa Carballeda as lead sponsor.

NCT NCT04517162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Collagen-Polyvinylpyrrolidone for the Treatment of Hyperinflammation and the Pulmonary Fibrosis in COVID-19 Patients. Double Blind Placebo-controlled Pilot Trial
Lead sponsor
Janette Furuzawa Carballeda
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 19, 2020
Completion date
June 19, 2021
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, cytokine storm, pulmonary fibrosis, regulation of inflammatory response